| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Janet J. Maguire | Q51749680 |
| P2093 | author name string | Janet J Maguire | |
| P2860 | cites work | IRL-1620, a tumor selective vasodilator, augments the uptake and efficacy of chemotherapeutic agents in prostate tumor rats | Q79890365 |
| Biased Agonism of the Angiotensin II Type I Receptor | Q26801071 | ||
| ETA receptor‐mediated constrictor responses to endothelin peptides in human blood vessels in vitro | Q28367973 | ||
| Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling | Q34217961 | ||
| β-Arrestins regulate human cardiac fibroblast transformation and collagen synthesis in adverse ventricular remodeling | Q34603394 | ||
| Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis. | Q34624192 | ||
| Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve? | Q34660839 | ||
| Development and characterization of pepducins as Gs-biased allosteric agonists | Q34774416 | ||
| A cell permeable peptide targeting the intracellular loop 2 of endothelin B receptor reduces pulmonary hypertension in a hypoxic rat model | Q35060505 | ||
| Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling | Q35201347 | ||
| Arrestins 2 and 3 differentially regulate ETA and P2Y2 receptor-mediated cell signaling and migration in arterial smooth muscle. | Q35849415 | ||
| Endothelin receptors in human coronary artery and aorta | Q35873397 | ||
| Failure of BQ123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments | Q35873739 | ||
| Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis | Q37115261 | ||
| Recent developments in biased agonism | Q38200333 | ||
| β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells. | Q39023562 | ||
| Quantification of ligand bias for clinically relevant β2-adrenergic receptor ligands: implications for drug taxonomy. | Q39040325 | ||
| ETA-receptor antagonists or allosteric modulators? | Q39761886 | ||
| Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart. | Q41972819 | ||
| Endothelin-1 and endothelin-2 initiate and maintain contractile responses by different mechanisms in rat mesenteric and cerebral arteries | Q41974344 | ||
| Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist | Q42283587 | ||
| Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers | Q42705103 | ||
| Biased Agonism of Endogenous Opioid Peptides at the μ-Opioid Receptor. | Q44329832 | ||
| Defining the affinity and receptor sub-type selectivity of four classes of endothelin antagonists in clinically relevant human cardiovascular tissues | Q44547639 | ||
| β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling. | Q44686499 | ||
| Comparison of human ETA and ETB receptor signalling via G-protein and β-arrestin pathways | Q44767788 | ||
| Endothelin B receptor agonist, IRL-1620, enhances angiogenesis and neurogenesis following cerebral ischemia in rats | Q46986382 | ||
| What is pharmacological 'affinity'? Relevance to biased agonism and antagonism. | Q53149817 | ||
| G protein-coupled receptor modulation with pepducins: moving closer to the clinic | Q56648575 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | membrane protein | Q423042 |
| cell surface receptor | Q2476074 | ||
| mechanism of action | Q3271540 | ||
| P304 | page(s) | 30-33 | |
| P577 | publication date | 2016-02-17 | |
| 2016-08-15 | |||
| P1433 | published in | Life Sciences | Q5256275 |
| P1476 | title | Evidence for biased agonists and antagonists at the endothelin receptors | |
| P478 | volume | 159 |
Search more.